News

Pre-announcement ERDERA Clinical Trial Call 2026

Published on | 1 hour ago

Programmes
Health
The European Rare Diseases Research Alliance (ERDERA) will launch a Clinical Trial Call 2026 (ECTC) on 1 July 2026, supporting multinational, Good Clinical Practice (GCP)-compliant Phase I, Phase I/II and Phase II interventional clinical trials in rare diseases.

Priority areas: paediatric rare diseases; rapidly progressive rare diseases; and rare diseases with no approved therapeutic options or with substantial residual unmet medical need despite existing treatments.

How it works: A multi‑stage process with a mandatory Expression of Interest. 
  • Stage 0 – Expression of Interest: Deadline 10 September 2026
  • Stage 1 – Short Proposal Stage: Deadline 29 October 2026
  • Stage 2 – Support Stage: January – July 2027
  • Stage 3 – Full Proposal Stage: July – September 2027
  • Funding Decisions: February 2028


An information webinar for prospective applicants will be held on 6 July 2026 and will provide an overview of the call objectives, eligibility requirements, evaluation process and indicative timeline.

More information in the pre-announcement and on the ERDERA website (incl. draft Call text). 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1915 articles available search in articles 

Testimonial

GLAUKOS - Circular Solution for the Textile Industry

Bio Base Europe Pilot Plant coordinated the Glaukos project, which answered the call topic published in 2019 of Horizon 2020 Framework Programme ‘Develop bio-based fibres and/or functional molecules to improve the performance of textile products’ under the Framework of the Bio-based Industries Joint Undertaking (BBI JU). The consortium partners took up this challenge by valorising industrial side streams and setting up a circular approach to the textile industry.